Düx, Daniel M. https://orcid.org/0000-0003-3978-4458
Chodakiewitz, Yosef
Bitton, Rachelle
Sewell, Sharmila
Sheth, Vipul R.
Ghanouni, Pejman
Brunsing, Ryan L.
Funding for this research was provided by:
Focused Ultrasound Foundation
Article History
Received: 28 July 2024
Revised: 26 September 2024
Accepted: 15 November 2024
First Online: 21 January 2025
Compliance with ethical standards
:
: The scientific guarantors of this publication are Ryan Brunsing, MD, PhD.
: The authors of this manuscript declare relationships with the following companies: P.G.: Funding from INSIGHTEC. Advisory board for SonALAsense, Profound, and INSIGHTEC. Shareholder in SonALAsense. Consulted for HistoSonics, SONIRE, and Turing Medical. R.B.: Funding from GE Healthcare. The other co-authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all subjects (patients) or their legally authorized representatives in this study.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in Ghanouni P, et al []. Düx DM, Baal JD, Bitton R, Chen J, Brunsing RL, Sheth VR, Rosenberg J, Kim K, Ozhinsky E, Avedian R, Ganjoo K, Bucknor M, Dobrotwir A, Ghanouni P. (2024) MR-guided focused ultrasound therapy of extra-abdominal desmoid tumors: a multicenter retrospective study of 105 patients. Eur Radiol. .
: